5-Fluorouracil, folinic acid and oxaliplatin administered via hepatic arterial infusion as regional second-line therapy for advanced colorectal cancer

Oncology

Volumn 64, Issue 4, 2003, Pages 473-474

  Meyer, Lars ^a   Hildebrandt, Bert ^a   Riess, Hanno ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; TROPISETRON; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

ABDOMINAL PAIN; ADULT; ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; COLORECTAL CANCER; DIARRHEA; DRUG TOLERABILITY; HEPATIC ARTERY; HUMAN; LETTER; LIVER METASTASIS; MALE; NEUROTOXICITY; PRIORITY JOURNAL; REGIONAL PERFUSION; THROMBOCYTOPENIA; VOMITING; BLOOD; CLINICAL TRIAL; COLORECTAL TUMOR; GERMANY; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS; COLORECTAL NEOPLASMS; FLUOROURACIL; GERMANY; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; TREATMENT OUTCOME;

EID: 0038312204     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070309     Document Type: Letter

References (9)

1. Black RJ, Bray F, Ferlay J, et al: Cancer incidence and mortality in the European Union: Cancer registry data and estimates of national incidence for 1990. Eur J Cancer 1997;33:1075-1079.
2. Zadavski KE, Lee YTM: Liver metastases from colorectal carcinoma: Incidence, resectability, and survival results. Ann Surg 1994;60:929-932.
3. Lorenz M, Müller HH: Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol 2000;18:243-254.
4. Kornmann M, Beger HG, Link KH: Evaluation of toxicity using oxaliplatin for regional intraarterial chemotherapy in patients with colorectal liver metastases. 11. ICACT: AS05-02, 2001 (abstr).
5. Kern W, Beckert B, Lang N, et al: Hepatic arterial infusion with oxaliplatin, folinic acid, and 5-fluorouracil in patients with hepatic metastases from colorectal cancer: Role of carcino-embryonic antigen in assessment of response. Anticancer Res 2000;20(6D):4973-4975.
6. Kern W, Beckert B, Lang N, et al: Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer. Ann Oncol 2001;12:599-603.
7. Kemeny NE, Ron IG: Hepatic arterial chemotherapy in metastatic colorectal patients. Semin Oncol 1999;26:524-535.
8. Safi F, Bittner R, Roscher R, et al: Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intra-arterial versus continuous intra-arterial/intravenous therapy). Cancer 1989;64:379-387.
9. O'Connell M, Nagorney D, Bernath A, et al: Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver. J Clin Oncol 1998;16:2528-2533.